ATLANTA, GA–Stephanie Adams has replaced Anne Wein as executive director of Southeast BIO (SEBIO), the nonprofit biotech trade organization. Wein is moving to Indianapolis where her husband is starting a surgical fellowship.

Stephanie Adams takes the reins part time at SEBIO today. She assumes fulltime duties April 1. Friday was Wein’s last day after two years at the organization’s helm.

Adams has worked for King & Spalding in Atlanta for the last six years as a patent agent counseling life science clients. She is familiar with the Southeast life sciences community through her involvement with SEBIO, the Georgia Biomedical Partnership (GBP) and the Atlanta Biotech Network, now the Emerging Leaders Network of the GBP.

Adams also has a Ph.D. in molecular and systems pharmacology from Emory University.

SEBIO’s geographic footprint presently includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. North Carolina (#3), Georgia (#7) and Florida (#10) are among the top ten U.S. biotech centers, according to Ernst & Young’s Beyond Borders: The Global Biotechnology Report 2006.

SEBIO primarily facilitates the growth of the life sciences industry through its annual Investor Forum. The eighth annual SEBIO Investor Forum, which is set for November 8-10 in Atlanta, is expected to attract more than 500 attendees, including 150 investors from the Southeast and from around the world.

For more information see: www.sebio.org

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2007, TechJournal South. All rights reserved.